383 related articles for article (PubMed ID: 19644862)
1. Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et al.
Brucato A; Imazio M; Spodick D; Adler Y
Arthritis Rheum; 2009 Aug; 60(8):2543; author reply 2543-4. PubMed ID: 19644862
[No Abstract] [Full Text] [Related]
2. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
[TBL] [Abstract][Full Text] [Related]
3. Recurrent pericarditis: new and emerging therapeutic options.
Imazio M; Lazaros G; Brucato A; Gaita F
Nat Rev Cardiol; 2016 Feb; 13(2):99-105. PubMed ID: 26259934
[TBL] [Abstract][Full Text] [Related]
4. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases.
Lazaros G; Vasileiou P; Koutsianas C; Antonatou K; Stefanadis C; Pectasides D; Vassilopoulos D
Ann Rheum Dis; 2014 Dec; 73(12):2215-7. PubMed ID: 25165036
[No Abstract] [Full Text] [Related]
5. Treatment of acute and recurrent idiopathic pericarditis.
Lilly LS
Circulation; 2013 Apr; 127(16):1723-6. PubMed ID: 23609551
[No Abstract] [Full Text] [Related]
6. Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options.
Imazio M
Expert Rev Clin Immunol; 2014 Nov; 10(11):1487-92. PubMed ID: 25307995
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).
Vassilopoulos D; Lazaros G; Tsioufis C; Vasileiou P; Stefanadis C; Pectasides D
Int J Cardiol; 2012 Sep; 160(1):66-8. PubMed ID: 22704870
[No Abstract] [Full Text] [Related]
8. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
[TBL] [Abstract][Full Text] [Related]
9. Individualized therapy for pericarditis.
Imazio M; Brucato A; Trinchero R; Spodick D; Adler Y
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):965-75. PubMed ID: 19673674
[TBL] [Abstract][Full Text] [Related]
10. [Customized management of pericarditis].
Darioli V; Carballo D; Carballo S
Rev Med Suisse; 2010 Oct; 6(267):1957-60, 1962. PubMed ID: 21125728
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and management of pericarditis.
Imazio M
Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1221-33. PubMed ID: 21932964
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute gout.
Schlesinger N
Rheum Dis Clin North Am; 2014 May; 40(2):329-41. PubMed ID: 24703350
[TBL] [Abstract][Full Text] [Related]
13. Colchicine for pericarditis: hype or hope?
Imazio M; Brucato A; Trinchero R; Spodick D; Adler Y
Eur Heart J; 2009 Mar; 30(5):532-9. PubMed ID: 19190012
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.
Scardapane A; Brucato A; Chiarelli F; Breda L
Pediatr Cardiol; 2013; 34(8):1989-91. PubMed ID: 23052671
[TBL] [Abstract][Full Text] [Related]
15. Recurrent pericarditis in children and adolescents: a multicentre cohort study.
Imazio M; Brucato A; Pluymaekers N; Breda L; Calabri G; Cantarini L; Cimaz R; Colimodio F; Corona F; Cumetti D; Cuccio CD; Gattorno M; Insalaco A; Limongelli G; Russo MG; Valenti A; Finkelstein Y; Martini A
J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):707-12. PubMed ID: 27467459
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
[No Abstract] [Full Text] [Related]
17. Resistant or recurrent acute pericarditis: a new therapeutic opportunity?
Massardier C; Dauphin C; Eschalier R; Lusson JR; Soubrier M
Int J Cardiol; 2014 Dec; 177(2):e75-7. PubMed ID: 25449496
[No Abstract] [Full Text] [Related]
18. [Efficacy of colchicine in recurrent acute idiopathic pericarditis].
Cacoub P; Sbaï A; Wechsler B; Amoura Z; Godeau P; Piette JC
Arch Mal Coeur Vaiss; 2000 Dec; 93(12):1511-4. PubMed ID: 11211445
[TBL] [Abstract][Full Text] [Related]
19. Does colchicine decrease the rate of recurrence of acute idiopathic pericarditis treated with glucocorticoids?
Mager A; Talmor Y; Chezar Azzerad C; Iakobishvili Z; Porter A; Kornowski R; Hasdai D
J Cardiol; 2018 Apr; 71(4):409-413. PubMed ID: 29198919
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
